BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2008
View Archived Issues
Mechanisms underlying antiarrhythmic effects of sodium tanshinone IIA sulfonate explored
Read More
Lundbeck reports preclinical pharmacology data on its novel treatment for mood disorders
Read More
New compounds for psychiatric disorders disclosed in recent patent literature
Read More
p38 MAP kinase inhibitor series optimization leads to UCB-1277763
Read More
Egis Pharmaceuticals presents EGIS-11148, a pyridazinone antipsychotic
Read More
Study confirms long-term efficacy of Sativex in MS neuropathic pain
Read More
CV Therapeutics initiates phase I CVT-3619 trial for cardiometabolic diseases
Read More
Alvesco inhalation aerosol available in U.S. for asthma
Read More
Five Prime initiates phase I FP-1039 trial in advanced solid tumors
Read More
Logical Therapeutics initiates double-blind, randomized study of LT-NS-001
Read More
Novel therapeutic options for HCV infection described in recent patents
Read More
Recent Merck and AstraZeneca patents report new agents for treating Alzheimer's disease
Read More
Anticancer dual VEGFR-2/3 and Flt3 kinase inhibitors active in preclinical models
Read More
Amgen develops selective CB2 agonists for analgesia
Read More
Peplin commences phase III PEP-005 gel trial in actinic keratoses
Read More
New recombinant Xyntha available for patients with hemophilia A
Read More
DSMB recommends continuation of Stem Cell's phase IIb REGENESIS trial of NTx-265
Read More
Elan and Biogen initiate treatment in phase I/II clinical trial of Tysabri in oncology
Read More
FDA grants fast track status to Celgene's amrubicin in small cell lung cancer
Read More
QuatRx initiates second phase III study of Ophena in postmenopausal vaginal syndrome
Read More
Procter & Gamble acquires NIOXIN Research Laboratories
Read More
MediciNova presents preliminary results from phase II MN-221 trial in asthma
Read More
Oncolytics Biotech enrolls patients in U.S. phase II Reolysin trial
Read More
Metabolic presents update on proposed acquisition of PolyNovo Biomaterials
Read More
Clinical studies of Akela's Taifun to be initiated in Finland and Japan
Read More
